CareDx
Clinical trials sponsored by CareDx, explained in plain language.
Diagnostics company specializing in transplant monitoring tests.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New blood test could spot cancer return after transplant Results expected Oct 2026 (estimated)
- New registry monitors heart transplant patients for better rejection detection Results expected Nov 2026 (estimated)
-
New registry monitors heart transplant patients for better rejection detection
Knowledge-focused OngoingThis study follows over 2,700 heart transplant recipients to see how well HeartCare testing services work in routine care. Researchers will track whether patients develop certain antibodies that may signal rejection. The goal is to understand if regular monitoring helps catch pro…
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New blood test could spot cancer return after transplant
Knowledge-focused OngoingThis study is testing a new blood test called AlloHeme that measures how much of a patient's own cells remain after a bone marrow transplant. The goal is to see if this test can predict whether the cancer (acute leukemia or myelodysplastic syndrome) will come back. About 307 adul…
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Blood test could transform liver transplant monitoring
Knowledge-focused OngoingThis study is testing a new blood test called LiverCare to see if it can better monitor liver transplant recipients for complications like rejection. Researchers will follow 1,500 patients for up to a year, comparing the new test with standard monitoring. The goal is to improve e…
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New blood test aims to catch lung transplant problems early
Knowledge-focused OngoingThis study is testing a blood test called AlloSure Lung in 550 lung transplant patients. The test looks for DNA from the donor lung in the patient's blood, which could signal rejection or infection. Researchers want to see how accurate the test is compared to standard monitoring.…
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC